Urothelial Cancer Drugs Market 2030: The Impact of Aging Populations
Global Urothelial Cancer Drugs Market Overview The global urothelial cancer drugs market was valued at USD 3.24 billion in 2023 and is projected to reach USD 6.78 billion by 2030, growing at a compound annual growth rate (CAGR) of 11.1% from 2024 to 2030. This robust growth is primarily driven by the increasing prevalence of urothelial cancer, especially bladder cancer. Advancements...
0 Kommentare 0 Geteilt 46 Ansichten